Episode 1: The Impact of Covid-19 and Future Pandemics on Getting Advanced Therapies to Patients

Episode one of Phacilitate Talks features Lindsey Clarke the European Head of Cell and Gene Therapy at bio-techne, Anthony Davies, CEO of Dark Horse Consulting and Cenk Sumen, CTO of Stemson Therapeutics.

Join us to hear how their teams have adjusted to remote work, their perspective on how Covid-19 has impacted clinical trials and what we do as global community to better prepare for the next pandemic.